CollPlant Biotechnologies Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Stock Rating
7
Price Target
$16.88
Consensus
Outperform
Upside
204.14%
Analysts
0
Stock Rating
7
Upside
204.14%
Analysts
0
Price Target
$16.88
CollPlant Biotechnologies Stock Forecast and Price Target
The average price target of $16.88 for CollPlant Biotechnologies's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 204.14% from the last closing price in February, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $22.75 and a low estimate of $11.00. Even if you are not interested in CLGN stock, it is still crucial to be aware of its competitors.
$16.88
204.14% Upside
Buy
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$145.74 | Buy/Sell | $174.55 | 16.65% |
| ABBV Stock Forecast | AbbVie | Outperform |
9
|
$164.66 | Buy/Sell | $178.42 | 14.78% |
| SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$327.45 | Buy/Sell | $353.16 | 11.93% |
| COLO B Stock Forecast | Coloplast A/S | Hold |
18
|
kr896.20 | Buy/Sell | kr812.28 | 1.54% |
| ZBH Stock Forecast | Zimmer Biomet Holdings | Hold |
15
|
$119.33 | Buy/Sell | $132.52 | 13.97% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SN. Stock Forecast | Smith & Nephew | Outperform |
18
|
£9.67 | Buy/Sell | £16.09 | 69.70% |
| CTEC Stock Forecast | ConvaTec Group PLC | Outperform |
16
|
£2.84 | Buy/Sell | £3.43 | 39.79% |
| IART Stock Forecast | Integra LifeSciences Holdings | Hold |
16
|
$31.63 | Buy/Sell | $46.60 | 37.53% |
.jpg)
Site Navigation
.jpg)